SCHEMBL7330994

SCHEMBL7330994

CN(C(=O)c1ccccc1)c1nc2ccc(C(=N)N)cc2c(=O)o1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ELANE P08246 6/20 0.51
PLAU P00749 3/20 0.50
F10 P00742 1/20 0.39
C1R P00736 5/20 0.39
PRSS1 P07477 3/20 0.38
LMNA P02545 2/20 0.38
ITGB3 P05106 1/20 0.38
ITGA2B P08514 1/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
CASP3 P42574 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7331994 0.92 ELANE (0.53) ELANEPLAUF10C1RPRSS1
SCHEMBL7329441 0.88 ELANE (0.63) ELANEPLAUC1RPRSS1
SCHEMBL7332655 0.88 ELANE (0.59) ELANEPLAUF10C1RPRSS1
SCHEMBL7337855 0.86 ELANE (0.48) ELANEPLAUC1RPRSS1NPC1
SCHEMBL7333539 0.81 ELANE (0.74) ELANEC1RPRSS1LMNANPC1
SCHEMBL7333378 0.81 ELANE (0.50) ELANEC1RPRSS1LMNASMN1; SMN2
SCHEMBL7338273 0.80 ELANE (0.58) ELANEC1RPRSS1KDM4EALDH1A1
SCHEMBL7335865 0.77 NPC1 (0.54) PLAUF10PRSS1LMNAITGB3
SCHEMBL7333376 0.77 ELANE (0.54) ELANEC1RPRSS1NPC1TP53
SCHEMBL7363986 0.76 ELANE (0.66) ELANEC1RPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5652237-A 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes WARNER-LAMBERT COMPANY (US) 1997-07-29 US claimed
WO-1996007648-A1 2-SUBSTITUTED-4H-3,1-BENZOXAZIN-4-ONES AND BENZTHIAZIN-4-ONES AS INHIBITORS OF COMPLEMENT Clr PROTEASE FOR THE TREATMENT OF INFLAMMATORY PROCESSES WARNER-LAMBERT COMPANY (US) 1996-03-14 WO claimed
US-5652237-A 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes WARNER-LAMBERT COMPANY (US) 1997-07-29 US disclosed
WO-1996007648-A1 2-SUBSTITUTED-4H-3,1-BENZOXAZIN-4-ONES AND BENZTHIAZIN-4-ONES AS INHIBITORS OF COMPLEMENT Clr PROTEASE FOR THE TREATMENT OF INFLAMMATORY PROCESSES WARNER-LAMBERT COMPANY (US) 1996-03-14 WO disclosed